![1610758-20-7 | O-(2-Ethylbutyl) Dabigatran Ethyl Ester | N-[[2-[[[4-[[[(2-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine Ethyl Ester; Dabigatran Impurity C | C₃₇H₃₈N₇O₅ | TRC 1610758-20-7 | O-(2-Ethylbutyl) Dabigatran Ethyl Ester | N-[[2-[[[4-[[[(2-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine Ethyl Ester; Dabigatran Impurity C | C₃₇H₃₈N₇O₅ | TRC](https://www.trc-canada.com/prod-img/E900655.png)
1610758-20-7 | O-(2-Ethylbutyl) Dabigatran Ethyl Ester | N-[[2-[[[4-[[[(2-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine Ethyl Ester; Dabigatran Impurity C | C₃₇H₃₈N₇O₅ | TRC
![Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/b383c608-ca13-4c76-9b23-d4f810ca8d9c/jah35265-fig-0001.png)